Atezolizumab/pembrolizumabVarious toxicities: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1940卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31947-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：89 / 89

相关论文

共 50 条

[1] Atezolizumab/dapsone/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2024, 2027 (1) : 81 - 81
[2] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2020, 1806 (1) : 59 - 59
[3] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 20 case reports
Reactions Weekly, 2025, 2042 (1) : 63 - 63
[4] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2023, 1963 (1) : 101 - 101
[5] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 15 case reports
Reactions Weekly, 2024, 2032 (1) : 72 - 72
[6] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1867 (1) : 71 - 71
[7] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1707 (1) : 56 - 56
[8] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 35 case reports
Reactions Weekly, 2019, 1740 (1) : 52 - 52
[9] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 24 case reports
Reactions Weekly, 2022, 1924 (1) : 94 - 94
[10] Atezolizumab/ipilimumab/nivolumab/pembrolizumabVarious toxicities: 49 case reports
Reactions Weekly, 2020, 1816 (1) : 72 - 72

← 1 2 3 4 5 →